checkAd

     117  0 Kommentare Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing - Seite 3

    Investor Contact:
    Carlos Ramirez
    Senior Vice President, Celularity Inc.
    Carlos.ramirez@celularity.com

    Media Contact:
    Ali Nagy / Michaela Fawcett
    KCSA Strategic Communications
    anagy@kcsa.com / mfawcett@kcsa.com



    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3
    Verfasst von globenewswire
    Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing - Seite 3 FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) - Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that on …

    Schreibe Deinen Kommentar

    Disclaimer